other: Strains Matter: GR-1/RC-14 and Vaginal Flora
claim: In one randomized clinical trial, 82% of women studied had healthy vaginal flora after 28 days of use at 1.6 billion CFU per day of a probiotic (formulated with L. rhamnosus, GR-1 and L. reuteri, RC-14) compared to 50% before supplementation. Whereas in the control group (taking 10 billion CFU of common strain, L. rhamnosus GG) there was no improvement in the percentage of women with healthy vaginal flora.
Reid et al. (2001). FEMS Immunol. Med. Microbiol. GR-1 and RC-14 are trademarks of Chr. Hansen A/S.
other: IPRO
Non GMO Project Verified
Nongmoproject.org
other: Suggested Use: Adults take 1 capsule once a day. May be taken with or without food. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.
other: Clinically Effective Probiotic Strains
Over 30 years of clinical research supports the effectiveness of the 2 patented probiotic bacterial strains in Fem-Dophilus. These beneficial strains populate the vaginal tract with healthy bacteria to balance the vaginal microbiome and help maintain a healthy vaginal and urinary tract. These two strains are the most clinically published strains for vaginal health worldwide, and were carefully selected due to their effectiveness in these studies.
A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid, enhances probiotic bacterial survival to the lower intestine, and into the vaginal tract. Additionally, the package contains a smaller, Activ-Vial moisture-controlled desiccant bottle for better stability of probiotic bacteria.
As of 8/1/2022
warning: Warning: Consult a healthcare professional before using this product if you are pregnant, nursing, under the age of 18, are taking medication or have a medical condition; if adverse reactions occur, discontinue use.
warning: Warning: Consult a healthcare professional before using this product if you are pregnant, nursing, under the age of 18, are taking medication or have a medical condition; if adverse reactions occur, discontinue use.
warning: Keep out of the reach of children.
other: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
other: Over 30 years of clinical research supports the effectiveness of the 2 patented probiotic bacterial strains in Fem-Dophilus.
Copyright 2023 Jarrow Formulas
other: Vegan
other: Keep refrigerated
other: 5 billion CFU
2 Clinically effective strains
Maintains and balances vaginal microbriome and urinary tract health with GR-1 & RC-14 strains
other: Vaginal & urinary tract
claim: 30+ years of clinical research
other: Non-GMO
Gluten free
identity: Probiotic Supplement
warning: Do not use if safety seal is damaged or missing.
other: No wheat, gluten, soybeans, dairy, egg, fish/shellfish, peanuts/tree nuts or sesame.
other: Minimum 5 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date.
other: Minimum 5 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date.
other: Reid et al. (2001). FEMS Immunol. Med. Microbiol. GR-1 and RC-14 are trademarks of Chr. Hansen A/S.
Label facts as declared by the manufacturer to the NIH Dietary Supplement Label Database (DSLD), not independently
lab-tested. This page reports what the label says; it does not rate, score, or recommend this product.